Yttrium-90 - current status, expected availability and applications of a high beta energy emitter

Current Radiopharmaceuticals

Volumn 5, Issue 3, 2012, Pages 253-263

  Leyva Montana R ^a   Hernandez Gonzalez I ^a   Alberti Ramirez, A ^a   Garaboldi, L ^b   Chinol, M ^b  

^a Isotopes Center   (Cuba)

^b EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Antibody radiolabeling; Biotin radiolabeling; Pre targeting approach

Indexed keywords

BIOTIN; EDETIC ACID; IBRITUMOMAB TIUXETAN; NIMOTUZUMAB; STRONTIUM 90; TETRAXETAN; YTTRIUM 90;

ADSORPTION; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BIOAVAILABILITY; BREAST CANCER; CATION EXCHANGE; CUBA; ELECTROCHEMICAL ANALYSIS; EXTERNAL BEAM RADIOTHERAPY; HUMAN; ISOTOPE LABELING; NEUROENDOCRINE TUMOR; NONHODGKIN LYMPHOMA; NONHUMAN; POLAROGRAPHY; PRIORITY JOURNAL; PROTEIN TARGETING; PURIFICATION; RADIATION DOSE; RADIOACTIVE WASTE PROCESSING; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 84863557048     PISSN: 18744710     EISSN: 18744729     Source Type: Journal    
DOI: 10.2174/1874471011205030253     Document Type: Article

References (35)

1. Zalutsky, M.R. In: Antibodies in Radiodiagnosis and Therapy; Zalutsky, M.R., Ed.; CRC Press: Boca Raton, Florida, 1989, pp 3-235.
2. Bodei, L.; Paganelli, G. In: Radionuclide Peptide Cancer Therapy. Chinol, M; Paganelli, G. Eds.; Taylor & Francis: New York, 2006, pp 221-231.
3. Knapp, F. F; Callahan, A.P.; Beets, A. L; Mirzadeh, S.; Hsieh, B. Processing of reactor-produced tungsten-188 for fabrication of clinical scale alumina-based tungsten-188/rhenium-188 generators. Appl. Radiat. Isot.,1994, 45, 1123-1128.
4. 90. J. Nucl. Med., 1963, 4, 54-59.
5. Qaim, S.M. Therapeutic radionuclides and nuclear data. Radiochim. Acta., 2001, 89, 297-302.
6. Magill, J.; Pfenning, G.; Galy, J. Karlsruher Nuclidkarte, 7th ed.;. European Commission, DG, JRC, ITU: Karlsruhe, Germany, 2006.
7. Wessels, B.W.; Rogus, R.D. Radionuclide selection and model absorbed dose calculation for radiolabeled tumor associated antibodies. Med. Phys., 1984, 11, 638-645.
8. Chinol, M.; Grana, C.; Gennari, R.; Cremonesi M.; Geraghty, J.G.; Paganelli, G. In: Radioimmunotherapy of cancer; Abrams, P.G., Frietzberg, A.R., Eds.; Marcel Dekker: New York, 2000; pp 169-193.
9. Juweid, M.; Sharkey, R.M.; Goldenberg, D.M. In: Cancer radioimmunotherapy: Present and Future; Riva, P. Ed.; Harwood Academic Publishers: Switzerland, 1999, pp 231-244.
10. 90Y-biotin. Eur. J. Nucl. Med., 1999, 26, 348-357.
11. Otte, A.; Mueller-Brand, J.; Dellas, S.; Nitzche, E.U.; Herrmann, R.; Maecke, H.R. Yttrium-90-labelled somatostatin-analogue for cancer treatment. Lancet, 1998, 351, 417-418.
12. 90Y) ibritumomab tiuxetan (Zevalin) induces long-term durable resposes in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma. Cancer Biother. Radiopharm., 2005, 20, 185-188.
13. 90Y radioisotope generator. Int. J. Appl. Radiat. Isot., 1978, 29, 91-96.
14. 90Y generator for medical purpose. J. Radioanal. Nucl. Chem., 2000, 245, 403-406.
15. ICRP Publication 30, Part 1.; 1979, Vol.2, pp. 77-78.
16. 90Sr impurities in freshly "generator eluted" 90Y for radiopharmaceutical preparation. Appl. Radiat. Isot., 2009, 67, 1874-1877.
17. 90Y generator. Radiochim. Acta, 2005, 93, 111-113.
18. Chinol, M.; Franceschini, R., Paganelli, G.; Pecorale, A.; Paiano, A. In: Radioactive isotopes in clinical medicine and research XXII; Bergmann, H.; Kroiss, A.; Sinzinger, H. Eds.; Birkhauser Verlag: Basel, Switzerland, 1997, pp 327-332.
19. Chinol, M.; Hnatowich, D.J. Generator produced yttrium-90 for radioimmunotherapy. J. Nucl. Med., 1987, 28, 1465-1470.
20. 188Re generators; International Atomic Energy Agency: Vienna, Austria, 2009, pp. 57-71.
21. Horwitz, E.P.; Dietz, M.L. Process for the separation and purification of yttrium-90 for medical applications, United States Patent No. 5368736, Nov. 29, 1994.
22. 90Y for clinical use. Radiochim. Acta, 2009, 97, 739-746.
23. nd Ed; Academic Press: London, 2003, pp 445-463.
24. 90Y suitable for targeted therapy. Nucl. Med. Biol., 2008, 35, 245-253.
25. 86Y based on electrochemical separation. Appl. Radiat. Isot., 2009, 67, 523-529.
26. Groppi, F; Bonardi, M.; Birattari, C.; Gini, L. Determination of 90-Sr impurities in [90Y] labelled avidin-biotin for systemic radionuclide therapy, by liquid scintillation counting. J. Labelled. Compd. Radiopharm., 2001, 44, S747-S749.
27. Dietz, M. Horwitz, E.P. Improved chemistry for production of yttrium-90 for medical applications. Appl. Radiat. Isot., 1992, 43, 1093-1101.
28. Veronesi, U.; Orecchia, R.; Luini, A.; Galimberti, V.; Gatti, G.; Intra, M. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery: experience with 590 cases. Ann. Surg., 2005, 242, 101-106.
29. Wilchek, M.; Bayer, E.A. The avidin-biotin complex in immunology. Immunol. Today, 1984, 5, 39-48.
30. Li, M.; Meares, C.F. Synthesis, metal chelate stability, and enzyme digestion of a peptide-linked DOTA derivative and its corresponding radiolabeled immunoconjugates. Bioconj. Chem., 1993, 4, 275-283.
31. Sabatino, G.; Chinol, M.; Paganelli, G.; Papi, S.; Chelli, M.; Leone, G.; Papini, A.M.; De Luca, A.; Ginanneschi, M. A new biotin derivative-DOTA conjugate as a candidate for pretargeted diagnosis and therapy of tumors. J. Med. Chem., 2003, 46, 3170-3173.
32. Paganelli, G.; Ferrari, M.; Cremonesi, M.; De Cicco, C.; Galimberti, V.; Luini, A.; Veronesi, P.; Fiorenza, M.; Carminati, P.; Zanna, C.; Orecchia, R.; Veronesi, U. IART®: Intraoperative avid ination for radionuclide treatment. A new way of partial breast irradiation. The Breast, 2007, 16, 17-26.
33. Paganelli, G.; Ferrari, M.; Ravasi, L.; Cremonesi, M.; De Cicco, C.; Galimberti, V.; Sivolapenko, G.; Luini, A.; De Santis, R.; Travaini, L.L.; Fiorenza, M.; Chinol, M.; Papi, S.; Zanna, C.; Carminati, P.; Veronesi, U. Intraopearative avidination for radionuclide therapy: a prospective new development to accelerate radiotherapy in breast cancer. Clin. Cancer Res., 2007, 13 (Suppl 18), 5646s-5651s.
34. 90Y-labeled biotin. Eur. J. Nucl. Med. Mol. Imaging, 2010, 37, 203-211.
35. Urbano, N.; Papi, S.; Ginanneschi, M.; De Santis, R.; Pace, S.; Lindstedt, R.; Ferrari, L.; Choi, S.J.; Paganelli, G.; Chinol, M. Evaluation of a new biotin-DOTA conjugate for pretargeted antibody guided radioimmunotherapy (PAGRIT®). Eur. J. Nucl. Med. Mol. Imaging, 2007, 34, 68-77.